Key result
Parenteral thiamine linked to ~100% survival to discharge in thiamine-responsive acute pulmonary hypertension.
Why the study?
Right ventricular failure due to thiamine-responsive acute pulmonary hypertension (TRAPH) is a rarer manifestation of thiamine deficiency that is well described in children but uncommon among adults. This study examined the clinical presentation, differential diagnoses, therapy, and associated diseases of adult TRAPH cases.
Observational (n=52)
No
In the largest reported adult cohort of thiamine-responsive acute pulmonary hypertension (n=52), parenteral thiamine rapidly reversed acute right heart failure and severe lactic acidosis with 100% survival, underscoring the need to consider thiamine deficiency in patients mimicking acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Supports empiric thiamine in unexplained acute PH; extends case reports but leaves open randomized confirmation.
Purpose: Right ventricular failure due to acute pulmonary hypertension is among the rarer manifestations of thiamine deficiency as compared to the more well-known manifestations of dry and wet beriberi. Although well described in children, such a presentation, also known as thiamine responsive acute pulmonary hypertension (TRAPH), is uncommon among adults. Our study aims to examine the clinical presentation of adult TRAPH cases, the differential diagnoses considered, therapy, and associated diseases. To our knowledge, this study would be among the largest collections of adult TRAPH cases. Patients and Methods: We performed a retrospective observational study of cases of pulmonary hypertension secondary to thiamine deficiency at a tertiary care hospital in India from 2017– 2022. All patients were diagnosed with TRAPH through a diagnosis of exclusion and therapeutic trial of thiamine. Results: The study included 52 patients diagnosed with TRAPH. The median age was 40.5 years with male (90.4%) preponderance. The majority of patients presented with symptoms of cardiac failure, including dyspnea (35, 67.3%) and bilateral pedal edema (24, 46.2%) and displayed markers of acute pulmonary hypertension as seen on echocardiography through marked dilation of the right atrium (43, 87.8%) and right ventricle (28, 54.9%), and tricuspid regurgitation ranging from mild to severe. Acute kidney injury, congestive hepatitis and metabolic acidosis were the most common complications encountered. Clinical improvement was observed in all cases following thiamine administration. Conclusion: Thiamine deficiency should be considered in cases presenting with symptoms similar to acute pulmonary embolism, particularly when there are risk factors for thiamine deficiency and no clear risk factors for pulmonary embolism. Recognizing TRAPH can prevent unnecessary diagnostic delays, unwarranted investigations, and facilitate earlier initiation of targeted therapy to ultimately improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Gujral et al. (2026) conducted an observational in Thiamine-responsive acute pulmonary hypertension (TRAPH) and right ventricular failure (n=52). Parenteral thiamine supplementation was evaluated on Clinical improvement and survival to hospital discharge. Parenteral thiamine administration led to clinical improvement and 100% survival to discharge in all 52 adults with thiamine-responsive acute pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: